antitubercular activity against mtb atcc 35801 (ATCC)
95
Structured Review
ATCC
antitubercular activity against mtb atcc 35801
Antitubercular Activity Against Mtb Atcc 35801, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 386 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antitubercular+activity+against+mtb+atcc+35801/Mycobacterium+tuberculosis+(Zopf)+Lehmann+and+Neumann/pm32814528-78-4-8
Average 95 stars, based on 386 article reviews
Antitubercular Activity Against Mtb Atcc 35801, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 386 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antitubercular+activity+against+mtb+atcc+35801/Mycobacterium+tuberculosis+(Zopf)+Lehmann+and+Neumann/pm32814528-78-4-8
Average 95 stars, based on 386 article reviews
antitubercular activity against mtb atcc 35801 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Activity Assay:Article Title: Hybridization Approach to Drug Discovery Inhibiting Mycobacterium tuberculosis -An Overview. Article Snippet: Tuberculosis is one of the top 10 causes of death worldwide and the leading cause of death from a single infectious agent, mainly due to Mycobacterium tuberculosis (MTB).. Recently, clinical prognoses have worsened due to the emergence of multi-drug resistant (MDR) and extensive-drug resistant (XDR) tuberculosis, which lead to the need for new, efficient and safe drugs.. Among the several strategies, polypharmacology could be considered one of the best solutions, in particular, the multitarget directed ligands strategy (MTDLs), based on the synthesis of hybrid ligands acting against two targets of the pathogen. |